Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Peter Lipp

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Mycoses|December 4, 2010
Posaconazole: clinical pharmacokinetics and drug interactionsHans-Peter Lipp
Pharmazie in Unserer Zeit|June 24, 2004
[Clinical and pharmacoeconomic aspects. Selection criteria for anticoagulants]Hans-Peter Lipp
Frontiers in Human Neuroscience|November 24, 2025
The cost of language: functionally over-dominant language circuits in the human brain may limit cognitive abilities and non-verbal executive functionsHans-Peter Lipp
Medizinische Monatsschrift Fur Pharmazeuten|November 1, 2008
[Determination of individual kidney function?]Hans-Peter Lipp
British Journal of Clinical Pharmacology|September 16, 2010
Clinical pharmacodynamics and pharmacokinetics of the antifungal extended-spectrum triazole posaconazole: an overviewHans-Peter Lipp
Medizinische Monatsschrift Fur Pharmazeuten|March 5, 2013
[Clostridium difficile infection as interdisciplinary challenge. Current discussions in respect to epidemiology, diagnostic methods, risk classification as well as treatment options]Hans-Peter Lipp
Mycoses|May 28, 2008
Antifungal agents--clinical pharmacokinetics and drug interactionsHans-Peter Lipp
The European Journal of Neuroscience|June 11, 2009
Towards the neurobiology of large-scale spatial cognition (Commentary on Gagliardo et al.)Hans-Peter Lipp
Medizinische Monatsschrift Fur Pharmazeuten|April 2, 2010
[Extra- and paravasation of cytotoxic drugs. Pathomechanisms and current preventive measures]Hans-Peter Lipp
Pharmazie in Unserer Zeit|April 8, 2003
[Clinical development of antimycotics. Medical challenges]Hans-Peter Lipp
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Mycoses|December 4, 2010
Posaconazole: clinical pharmacokinetics and drug interactionsHans-Peter Lipp
Pharmazie in Unserer Zeit|June 24, 2004
[Clinical and pharmacoeconomic aspects. Selection criteria for anticoagulants]Hans-Peter Lipp
Frontiers in Human Neuroscience|November 24, 2025
The cost of language: functionally over-dominant language circuits in the human brain may limit cognitive abilities and non-verbal executive functionsHans-Peter Lipp
Medizinische Monatsschrift Fur Pharmazeuten|November 1, 2008
[Determination of individual kidney function?]Hans-Peter Lipp
British Journal of Clinical Pharmacology|September 16, 2010
Clinical pharmacodynamics and pharmacokinetics of the antifungal extended-spectrum triazole posaconazole: an overviewHans-Peter Lipp
Medizinische Monatsschrift Fur Pharmazeuten|March 5, 2013
[Clostridium difficile infection as interdisciplinary challenge. Current discussions in respect to epidemiology, diagnostic methods, risk classification as well as treatment options]Hans-Peter Lipp
Mycoses|May 28, 2008
Antifungal agents--clinical pharmacokinetics and drug interactionsHans-Peter Lipp
The European Journal of Neuroscience|June 11, 2009
Towards the neurobiology of large-scale spatial cognition (Commentary on Gagliardo et al.)Hans-Peter Lipp
Medizinische Monatsschrift Fur Pharmazeuten|April 2, 2010
[Extra- and paravasation of cytotoxic drugs. Pathomechanisms and current preventive measures]Hans-Peter Lipp
Pharmazie in Unserer Zeit|April 8, 2003
[Clinical development of antimycotics. Medical challenges]Hans-Peter Lipp
Pageof 13